Cargando…

Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy

BACKGROUND: The relationship between polymorphisms in vascular endothelial growth factor (VEGF) and gastric cancer is still inconclusive. We investigated whether there is an association between VEGF genetic polymorphisms and risk of gastric cancer, and evaluated the recurrence of advanced gastric ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Yeon-Ji, Chung, Woo Chul/, Jun, Kyong-Hwa, Chin, Hyung-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532236/ https://www.ncbi.nlm.nih.gov/pubmed/31117964 http://dx.doi.org/10.1186/s12885-019-5702-5

Ejemplares similares

Cost-effectiveness of adjuvant chemotherapy for curatively resected gastric cancer with S-1
por: Hisashige, Akinori, et al.
Publicado: (2013)

Adjuvant chemotherapy in curatively resected rectal cancer: How valid are the data?
por: Manzini, Giulia, et al.
Publicado: (2020)

Pre-operative serum vascular endothelial growth factor can select patients for adjuvant treatment after curative resection in colorectal cancer
por: Chin, K-F, et al.
Publicado: (2000)

Impact of Adjuvant Chemotherapy in Patients With Curatively Resected Stage IV Colorectal Cancer
por: Kobayashi, Hirotoshi, et al.
Publicado: (2015)

Independent Risk Factors of Early Recurrence After Curative Resection for Perihilar Cholangiocarcinoma: Adjuvant Chemotherapy May Be Beneficial in Early Recurrence Subgroup
por: Zhao, Jian, et al.
Publicado: (2020)

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer
por: Fondevila, C, et al.
Publicado: (2004)

Association between adjuvant chemotherapy and survival in stage I gastric cancer patients after curative resection
por: Chen, Qiuying, et al.
Publicado: (2023)

The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients
por: Hsieh, Mei‐Chin, et al.
Publicado: (2016)

Cost-effectiveness of adjuvant chemotherapy with uracil–tegafur for curatively resected stage III rectal cancer
por: Hisashige, A, et al.
Publicado: (2008)

Randomized trial of adjuvant chemotherapy versus control after curative resection for gastric cancer: 5-year follow-up
por: Neri, B, et al.
Publicado: (2001)

Benefit of Adjuvant Traditional Herbal Medicine With Chemotherapy for Resectable Gastric Cancer
por: Lee, Yu Kyung, et al.
Publicado: (2018)

The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer
por: Oh, Sung Yong, et al.
Publicado: (2013)

Recurrence after ESD curative resection for early gastric cancer
por: Kamiya, Ayako, et al.
Publicado: (2021)

Update of Adjuvant Chemotherapy for Resected Gastric Cancer
por: Oh, Sang Cheul
Publicado: (2012)

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
por: Lee, Choong-kun, et al.
Publicado: (2019)

3′-UTR Polymorphisms in the Vascular Endothelial Growth Factor Gene (VEGF) Contribute to Susceptibility to Recurrent Pregnancy Loss (RPL)
por: An, Hui Jeong, et al.
Publicado: (2019)

Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection
por: Choi, J-H, et al.
Publicado: (2001)

The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis
por: Ng, Kheng-Seong, et al.
Publicado: (2023)

Early Recurrence of Pancreatic Cancer after Resection and During Adjuvant Chemotherapy
por: Fischer, Richard, et al.
Publicado: (2012)

Role of Vascular Endothelial Growth Factor (VEGF) and VEGF-R Genotyping in Guiding the Metastatic Process in pT4a Resected Gastric Cancer Patients
por: Scartozzi, Mario, et al.
Publicado: (2012)

The patterns and timing of recurrence after curative resection for gastric cancer in China
por: Liu, Dan, et al.
Publicado: (2016)

Association of Vascular Endothelial Growth Factor (VEGF) Gene Polymorphisms With Gastric Cancer and Its Development, Prognosis, and Survival
por: Liu, Weimin, et al.
Publicado: (2018)

Genetic polymorphisms of Vascular Endothelial Growth Factor (VEGF) associated with endometriosis in Nigerian women
por: Babah, Ochuwa Adiketu, et al.
Publicado: (2021)

Stereotactic Body Radiotherapy for Isolated Para-aortic Lymph Node Recurrence after Curative Resection in Gastric Cancer
por: Kim, Mi-Sook, et al.
Publicado: (2009)

Apurinic/apyrimidinic endonuclease 1 is associated with poor prognosis after curative resection followed by adjuvant chemotherapy in patients with stage III colon cancer
por: Song, Ji Hyeong, et al.
Publicado: (2022)

Role of adjuvant chemotherapy on recurrence and survival in patients with resected ampulla of Vater carcinoma
por: Park, Se Jun, et al.
Publicado: (2023)

Is there a survival benefit from adjuvant chemotherapy for patients with liver oligometastases from colorectal cancer after curative resection?
por: Pan, Zhizhong, et al.
Publicado: (2018)

Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy
por: Murakawa, Masaaki, et al.
Publicado: (2017)

Platelet release of Vascular Endothelial Growth Factor (VEGF) in patients undergoing chemotherapy for breast cancer
por: Kirwan, Cliona C, et al.
Publicado: (2009)

Surgical Resection of Recurrent Lung Cancer in Patients Following Curative Resection
por: Kim, Hyoung Soo, et al.
Publicado: (2006)

Adjuvant chemotherapy after curative D2 gastrectomy in Latin American patients with gastric cancer
por: Serrano, Mariana, et al.
Publicado: (2022)

Vascular endothelial growth factor (VEGF) polymorphism rs3025039 and atherosclerosis among older with hypertension
por: Shimizu, Yuji, et al.
Publicado: (2022)

Association of Vascular Endothelial Growth Factors (VEGFs) with Recurrent Miscarriage: A Systematic Review of the Literature
por: Abu-Ghazaleh, Nadine, et al.
Publicado: (2023)

Adrenocortical Carcinoma in an Adult: Eight Months without Recurrence after Resection and Adjuvant Chemotherapy
por: Siosaki, Marcos Duarte, et al.
Publicado: (2014)

Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
por: Qiu, Bin, et al.
Publicado: (2021)

The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)

Local recurrence after curative resection for rectal carcinoma: The role of surgical resection
por: Yun, Jung-A, et al.
Publicado: (2016)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Prognostic Factors and Recurrence Patterns in T4 Gastric Cancer Patients after Curative Resection
por: Zhu, Bao-Yan, et al.
Publicado: (2019)

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms
por: Berardi, Rossana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9f4rlqkige203bdirmn9q6ahpj